Company intelligence / Profile preview

Qianzhi BioTech

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Qianzhi BioTech is an early-stage biotechnology company based in Shanghai, China, specializing in the development of microbiome-based therapeutics. The company leverages a proprietary high-throughput screening and drug discovery platform to identify novel microbial strains and metabolites with therapeutic potential. Their research primarily focuses on addressing unmet medical needs in metabolic disorders, autoimmune diseases, and oncology through the modulation of the human gut microbiota. By integrating advanced metagenomics and bioinformatics, Qianzhi BioTech aims to translate complex microbiome data into targeted clinical interventions.

Therapeutic areas: ImmunologyOncologyMetabolic Disorders
Modalities: Small moleculeLive biotherapeutic product therapyMicrobial therapy
Industry: Biotech

Beyond the preview

Go deeper on Qianzhi BioTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qianzhi BioTech.

Explore the full profile